Identical twins with XLA requiring differing amounts of 20% subcutaneous immunoglobulin secondary to protein-losing enteropathy

J Allergy Clin Immunol Pract. 2018 May-Jun;6(3):1073-1074. doi: 10.1016/j.jaip.2017.11.030. Epub 2018 Jan 12.

Authors

Jennifer Lan¹, John Eshun², Jay Adam Lieberman³

Affiliations

¹ Department of Allergy and Immunology, The University of Tennessee Health Science Center, Memphis, Tenn.
² Department of Pediatric Gastroenterology, The University of Tennessee Health Science Center, Memphis, Tenn.
³ Department of Allergy and Immunology, The University of Tennessee Health Science Center, Memphis, Tenn. Electronic address: [email protected].

PMID: 29339123
DOI: 10.1016/j.jaip.2017.11.030

No abstract available

Publication types

Case Reports
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adolescent
Agammaglobulinemia / diagnosis
Agammaglobulinemia / therapy*
Body Weight
Disease Progression
Drug Dosage Calculations
Genetic Diseases, X-Linked / diagnosis
Genetic Diseases, X-Linked / therapy*
Humans
Immunoglobulin G / blood
Immunoglobulins / therapeutic use*
Inflammatory Bowel Diseases / diagnosis*
Infusions, Subcutaneous
Male
Protein-Losing Enteropathies / therapy*
Twins, Monozygotic

Substances

Immunoglobulin G
Immunoglobulins

Supplementary concepts

Bruton type agammaglobulinemia